X4 PHARMACEUTICALS, INC (XFOR) Operating cash flow 2016–2025
X4 PHARMACEUTICALS, INC (XFOR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$85.6MFY2025 · since FY2016: -$21.6M → -$85.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.6M | +34.6% |
| FY2024 | -$130.9M | -35.6% |
| FY2023 | -$96.5M | -25.2% |
| FY2022 | -$77.1M | -8.7% |
| FY2021 | -$70.9M | -20.5% |
| FY2020 | -$58.8M | -22.4% |
| FY2019 | -$48.1M | -89.0% |
| FY2018 | -$25.4M | -19.3% |
| FY2017 | -$21.3M | +1.5% |
| FY2016 | -$21.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More XFOR financial trends
XFOR RevenueXFOR Net incomeXFOR Net marginXFOR Gross profitXFOR Gross marginXFOR Operating incomeXFOR Operating marginXFOR Free cash flowXFOR Capital expendituresXFOR Return on equityXFOR Stock buybacksXFOR Dividends paidXFOR Total assetsXFOR Total liabilitiesXFOR Shareholders’ equityXFOR overview →